关键词：伴侣诊断测试；特定药物；监测；疾病药物作用
摘 要：Companion diagnostic tests are used to identify suitable patients for administering specific drugs and monitoring the prognosis of drug effects on the disease. This concept of combining a drug with a diagnostic test is known as predictive medicine or personalized medicine. A companion diagnostic test has the ability to predict the risks of the disease and monitor its therapeutic response. The tests enable physicians to make decisions on the type of drugs and dosage administration and thereby reduce the mortality rates associated with diseases such as cancer and neurodegenerative disorders. The demand for companion diagnostic tests is expected to grow at a significant rate during the forecast period. In 2013, the Americas dominated the Global Companion Diagnostics market and it was followed by the EMEA region. Together, these two regions accounted for 90 percent of the market revenue. However, the APAC region is expected to grow at the fastest rate during the forecast period because of the increase in the incidence of infectious diseases, the demand for targeted therapeutics, and the increased adoption of diagnostic products. The Global Companion Diagnostics market is expected to grow at a CAGR of 18.59 percent during the forecast period.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Global In-vitro Diagnostics Market

06.1.1 Market Size and Forecast

06.2 Global Companion Diagnostics Market

06.2.1 Market Overview

06.2.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Indication

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

16.1 Competitive Scenario

16.1.1 Key News

16.1.2 Acquisitions

16.1.3 Key Vendor Analysis 2013

16.2 Other Prominent Vendors

17. Key Vendor Analysis

17.1 Abbott Laboratories Inc.

17.1.1 Business Overview

17.1.2 Business Segmentation

17.1.3 Key Information

17.1.4 SWOT Analysis

17.2 Agilent Technologies Inc.

17.2.1 Business Overview

17.2.2 Business Segmentation

17.2.3 Key Information

17.2.4 SWOT Analysis

17.3 bioMérieux SA

17.3.1 Business Overview

17.3.2 Business Segmentation

17.3.3 Key Information

17.3.4 SWOT Analysis

17.4 Qiagen N.V.

17.4.1 Business Overview

17.4.2 Business Segmentation

17.4.3 Key Information

17.4.4 SWOT Analysis

17.5 Roche Holding AG

17.5.1 Business Overview

17.5.2 Business Segmentation

17.5.3 Key Information

17.5.4 SWOT Analysis

18. Other Reports in this Series